ANAB

ANAPTYSBIO, INC

Nasdaq · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

AnaptysBio is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting immune and inflammatory diseases, with a pipeline that includes treatments for conditions such as atopic dermatitis and other autoimmune disorders. The company also generates revenue through licensing and milestone payments from partnerships with larger pharmaceutical companies for antibodies originally discovered in its labs.

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Exchange

Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
RENTON HOLLINGSInsider	Sell	$249K	5,000at $49.87	Oct 1, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ANAB.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ANAB activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.